Pune: Serum Institute of India (SII) has sought approval from Drugs Controller General of India (DCGI) for Covishield to be administered in the form of booster dose.
In an application to drugs regulator DCGI, Prakash Kumar Singh, Director, Government and Regulatory Affairs at Serum Institute, has cited adequate vaccine stock in India and a necessity for a booster shot especially after the emergence of new coronavirus variants, PTI reported quoting sources.
SII further mentioned that UK’s Medicines and Healthcare products Regulatory Agency has already approved booster dose of Oxford-AstraZeneca’s ChAdOx1 nCoV-19 vaccine. Since Serum Institute is manufacturing the same vaccine in a different brand name (Covishield), it’s only logical that India should embrace it.
Also Read: Omicron-Specific Booster Shot Possible, Says Adar Poonawala
Unlike countries like the US, UK, Germany, India has not decided on introducing a booster shot for its citizens. But a decision on the matter may be announced soon.
Also Read: COVID Vaccine: Policy On Booster & Additional Dose To Be Made Public In 2 Weeks
Bhubaneswar: Three eminent personalities were conferred honorary D.Litt degrees for their outstanding academic excellence and…
Berhampur: Indian Navy ship INS Kuthar docked in Gopalpur port in Odisha's Ganjam district with…
Jajpur: Ruling BJP and Opposition BJD were engaged in trading charges against each other on…
Perth: It was the perfect day of Test cricket for Team India. The visiting team…
Angul: A youth allegedly beat his old mother to death following an argument over a…
Perth: He hadn’t scored a Test century for 16 months. His previous 15 Test knocks…
Bhubaneswar: The members of BJD's minority cell staged a demonstration in front of Raj Bhavan…
Bhubaneswar: Dense fog reduced visibility in Odisha's Rourkela while moderate fog engulfed Koraput, Bhawanipatna and…